Increases in total cholesterol and low density lipoprotein associated with decreased cognitive performance in healthy elderly adults.


Journal

Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370

Informations de publication

Date de publication:
04 2019
Historique:
received: 02 05 2018
accepted: 19 12 2018
pubmed: 17 1 2019
medline: 14 8 2019
entrez: 17 1 2019
Statut: ppublish

Résumé

The current study examined associations between blood lipid profiles and cognitive functioning using a healthy non-demented elderly sample. The sample comprised 196 healthy volunteers (male; 86: female 110) aged 60-75 years from the Australian Research Council Longevity Intervention (ARCLI) study cohort. Serum total cholesterol (T-C), low density lipoprotein cholesterol (LDL-c), high density lipoprotein cholesterol (HDL-c) and triglycerides (TGL) were collected, and participants completed the Swinburne University Computerized Cognitive Assessment Battery (SUCCAB). In line with prediction, higher levels of T-C and LDL-c were found to be associated with impaired speeds of response in tasks assessing recognition memory, working memory and inhibitory processing. However, contrary to prediction both TGL and HDL-c were found to be unrelated to cognitive functioning in the current sample. It is suggested that frontal lobe function may be differentially sensitive to the effects of T-C and LDL-c accumulation during the aging process. Future data collection as part of the larger ARCLI intervention study will provide important follow-up data regarding the ability of the baseline blood lipid data to predict subsequent cognitive change.

Identifiants

pubmed: 30649667
doi: 10.1007/s11011-018-0373-5
pii: 10.1007/s11011-018-0373-5
doi:

Substances chimiques

Cholesterol, HDL 0
Cholesterol, LDL 0
Lipids 0
Triglycerides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

477-484

Références

J Gerontol B Psychol Sci Soc Sci. 2007 Mar;62(2):P112-8
pubmed: 17379671
J Alzheimers Dis. 2010;20(3):737-47
pubmed: 20413879
Dement Geriatr Cogn Disord. 2007;23(1):29-34
pubmed: 17068394
Ann N Y Acad Sci. 2002 Nov;977:367-75
pubmed: 12480774
Exp Aging Res. 2018 Mar-Apr;44(2):179-186
pubmed: 29303427
Metab Brain Dis. 2017 Aug;32(4):1089-1097
pubmed: 28374237
Clin Biochem Rev. 2007 May;28(2):32-45
pubmed: 17687413
Neurology. 2005 Apr 26;64(8):1378-83
pubmed: 15851727
Metab Brain Dis. 2016 Apr;31(2):465-73
pubmed: 26873100
Mol Neurodegener. 2009 Oct 24;4:42
pubmed: 19852847
Diabetes Care. 2007 Oct;30(10):2655-60
pubmed: 17563341
J Gerontol A Biol Sci Med Sci. 2008 Jun;63(6):619-24
pubmed: 18559637
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Biochim Biophys Acta. 2009 May;1792(5):470-81
pubmed: 18848880
Am J Clin Nutr. 2004 Aug;80(2):291-8
pubmed: 15277148
Nutr J. 2012 Mar 06;11:11
pubmed: 22390677
J Neurol Neurosurg Psychiatry. 2003 Nov;74(11):1530-5
pubmed: 14617710
Neurobiol Aging. 2003 Jan-Feb;24(1):147-55
pubmed: 12493560
Eur Neuropsychopharmacol. 2014 Jul;24(7):1056-66
pubmed: 24721317
Eur J Pharmacol. 2008 May 6;585(1):97-108
pubmed: 18395201
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Nat Rev Neurosci. 2004 Feb;5(2):87-96
pubmed: 14735112

Auteurs

Con Stough (C)

Centre for Human Psychopharmacology, Swinburne University of Technology, H24, PO Box 218, Hawthorn, Victoria, Australia.

Andrew Pipingas (A)

Centre for Human Psychopharmacology, Swinburne University of Technology, H24, PO Box 218, Hawthorn, Victoria, Australia.

David Camfield (D)

Centre for Human Psychopharmacology, Swinburne University of Technology, H24, PO Box 218, Hawthorn, Victoria, Australia. dcamfield@swin.edu.au.

Karen Nolidin (K)

Centre for Human Psychopharmacology, Swinburne University of Technology, H24, PO Box 218, Hawthorn, Victoria, Australia.

Karen Savage (K)

Centre for Human Psychopharmacology, Swinburne University of Technology, H24, PO Box 218, Hawthorn, Victoria, Australia.

Saurenne Deleuil (S)

Centre for Human Psychopharmacology, Swinburne University of Technology, H24, PO Box 218, Hawthorn, Victoria, Australia.

Andrew Scholey (A)

Centre for Human Psychopharmacology, Swinburne University of Technology, H24, PO Box 218, Hawthorn, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH